Open Study of Safety, Tolerability and Pharmacokinetic Parameters of Increasing Doses of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Subsequent Multiple Oral Administration in Healthy Volunteers
Latest Information Update: 21 Mar 2024
At a glance
- Drugs 4 methylumbelliferyl trimebutine sulfate (Primary)
- Indications Cholecystitis
- Focus Pharmacokinetics
- Sponsors Valenta Pharmaceuticals
- 21 Mar 2024 New trial record